Joel Greenblatt's PBH Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 24,171 shares of Prestige Consumer Healthcare Inc. (PBH) worth $1.49 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in PBH, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2014, adding 371,596 shares. Largest reduction occurred in Q4 2014, reducing 413,642 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Prestige Consumer Healthcare (PBH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Prestige Consumer Healthcare (PBH) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -12,529 | Reduce 34.14% | 24,171 | $61.69 |
| Q3 2025 | +24,867 | Add 210.15% | 36,700 | $62.40 |
| Q2 2025 | +4,333 | Add 57.77% | 11,833 | $79.85 |
| Q1 2025 | -910 | Reduce 10.82% | 7,500 | $85.97 |
| Q4 2024 | -1,578 | Reduce 15.80% | 8,410 | $78.09 |
| Q3 2024 | -492 | Reduce 4.69% | 9,988 | $72.10 |
| Q2 2024 | -242 | Reduce 2.26% | 10,480 | $68.85 |
| Q1 2024 | +99 | Add 0.93% | 10,722 | $72.56 |
| Q4 2023 | -337 | Reduce 3.07% | 10,623 | $61.22 |
| Q3 2023 | +84 | Add 0.77% | 10,960 | $57.19 |
| Q2 2023 | +1,153 | Add 11.86% | 10,876 | $59.43 |
| Q1 2023 | +2,687 | Add 38.19% | 9,723 | $62.63 |
| Q4 2022 | -2,682 | Reduce 27.60% | 7,036 | $62.60 |
| Q3 2022 | -2,419 | Reduce 19.93% | 9,718 | $49.80 |
| Q2 2022 | -6,579 | Reduce 35.15% | 12,137 | $58.83 |
| Q1 2022 | +6,519 | Add 53.45% | 18,716 | $52.95 |
| Q4 2021 | +1,531 | Add 14.35% | 12,197 | $60.67 |
| Q3 2021 | -3,102 | Reduce 22.53% | 10,666 | $56.07 |
| Q2 2021 | -612 | Reduce 4.26% | 13,768 | $52.08 |
| Q1 2021 | -22,861 | Reduce 61.39% | 14,380 | $44.09 |
| Q4 2020 | -5,208 | Reduce 12.27% | 37,241 | $34.88 |
| Q3 2020 | +17,136 | Add 67.70% | 42,449 | $36.42 |
| Q2 2020 | +9,581 | Add 60.90% | 25,313 | $37.57 |
| Q1 2020 | +361 | Add 2.35% | 15,732 | $36.68 |
| Q4 2019 | -2,503 | Reduce 14.00% | 15,371 | $40.53 |
| Q3 2019 | -7,421 | Reduce 29.34% | 17,874 | $34.69 |
| Q2 2019 | -13,393 | Reduce 34.62% | 25,295 | $31.67 |
| Q1 2019 | +1,365 | Add 3.66% | 38,688 | $29.91 |
| Q4 2018 | -24,739 | Reduce 39.86% | 37,323 | $30.89 |
| Q3 2018 | -77,625 | Reduce 55.57% | 62,062 | $37.90 |
| Q2 2018 | +21,403 | Add 18.09% | 139,687 | $38.38 |
| Q1 2018 | -25,809 | Reduce 17.91% | 118,284 | $33.72 |
| Q4 2017 | +39,050 | Add 37.18% | 144,093 | $44.41 |
| Q3 2017 | +64,737 | Add 160.61% | 105,043 | $50.09 |
| Q2 2017 | -85,770 | Reduce 68.03% | 40,306 | $52.82 |
| Q1 2017 | -3,195 | Reduce 2.47% | 126,076 | $55.56 |
| Q4 2016 | +76,682 | Add 145.81% | 129,271 | $52.10 |
| Q3 2016 | +34,910 | Add 197.47% | 52,589 | $48.26 |
| Q2 2016 | -1,162 | Reduce 6.17% | 17,679 | $55.38 |
| Q1 2016 | -23,432 | Reduce 55.43% | 18,841 | $53.39 |
| Q4 2015 | -76,905 | Reduce 64.53% | 42,273 | $51.47 |
| Q3 2015 | -150,298 | Reduce 55.77% | 119,178 | $45.16 |
| Q2 2015 | +194,130 | Add 257.65% | 269,476 | $46.24 |
| Q1 2015 | +68,618 | Add 1019.89% | 75,346 | $42.90 |
| Q4 2014 | -413,642 | Reduce 98.40% | 6,728 | $34.78 |
| Q3 2014 | +371,596 | Add 761.87% | 420,370 | $32.37 |
| Q2 2014 | -241,210 | Reduce 83.18% | 48,774 | $33.89 |
| Q1 2014 | +93,135 | Add 47.31% | 289,984 | $27.25 |
| Q4 2013 | +746 | Add 0.38% | 196,849 | $35.80 |
| Q3 2013 | +70,220 | Add 55.78% | 196,103 | $30.12 |
| Q2 2013 | +125,883 | Add 0.00% | 125,883 | $29.14 |
Joel Greenblatt's Prestige Consumer Healthcare Investment FAQs
Joel Greenblatt first purchased Prestige Consumer Healthcare Inc. (PBH) in Q2 2013, acquiring 125,883 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Prestige Consumer Healthcare Inc. (PBH) for 51 quarters since Q2 2013.
Joel Greenblatt's largest addition to Prestige Consumer Healthcare Inc. (PBH) was in Q3 2014, adding 420,370 shares worth $13.61 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 24,171 shares of Prestige Consumer Healthcare Inc. (PBH), valued at approximately $1.49 M.
As of the Q4 2025 filing, Prestige Consumer Healthcare Inc. (PBH) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Prestige Consumer Healthcare Inc. (PBH) was 420,370 shares, as reported at the end of Q3 2014.